Online inquiry

IVTScrip™ mRNA-Human ADGRG1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10741MR)

This product GTTS-WK10741MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRG1 protein. This product can be used in CD4+ cytotoxic T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001145770.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9289
UniProt ID Q9Y653
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRG1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10741MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK26183MR IVTScrip™ mRNA-Human ARHGAP15, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARHGAP15
GTTS-WK19705MR IVTScrip™ mRNA-Human ANKRD18DP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD18DP
GTTS-WK22676MR IVTScrip™ mRNA-Human ARRB2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARRB2
GTTS-WK22650MR IVTScrip™ mRNA-Human ARL6IP6, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARL6IP6
GTTS-WK25622MR IVTScrip™ mRNA-Human ARHGEF7, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF7
GTTS-WK20428MR IVTScrip™ mRNA-Human AHSP, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AHSP
GTTS-WK8033MR IVTScrip™ mRNA-Human ADGRB2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADGRB2
GTTS-WK13699MR IVTScrip™ mRNA-Human ADAMTS14, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADAMTS14
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →